Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03740334
Title Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Nemours/Alfred I. duPont Hospital for Children Wilmington Delaware 19803 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Boston Children's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10174 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field